Your thyroid results came back normal. The GP said so. TSH within range, nothing to worry about, come back if things don't improve. And yet here you are — still exhausted in a way that sleep doesn't fix, still watching the scale move in the wrong direction despite doing everything right, still finding hair on your pillow and in the shower drain in quantities that make you do a quiet double-take.
This is one of the most frustrating clinical paradoxes in women's hormonal health: a normal TSH result does not rule out meaningful thyroid dysfunction, particularly when PCOS/PMOS is also present. The two conditions share biological pathways that can suppress thyroid function while leaving standard screening results technically within range — and most GPs, through no fault of their own, treat them as entirely separate conditions.
Women with PCOS/PMOS have a 3–4 times higher rate of Hashimoto's thyroiditis compared to the general population. Up to 27% have subclinical hypothyroidism — thyroid function that is impaired enough to produce symptoms but not impaired enough to trigger a clinical diagnosis on a standard TSH test. These aren't rare edge cases. They're the statistical norm for a significant proportion of the PCOS/PMOS community.
The Shared Biology: Why PCOS/PMOS and Thyroid Dysfunction Compound Each Other
Understanding why these two conditions interact requires looking at four distinct mechanisms — each of which can produce symptoms independently, and all of which compound when they operate simultaneously.
Insulin resistance ↔ thyroid conversion
Insulin resistance — which affects the majority of women with PCOS/PMOS to some degree — directly impairs the conversion of T4 to T3. T4 is the form of thyroid hormone your thyroid gland produces. T3 is the active form that your cells actually use. The conversion happens primarily in the liver and peripheral tissues, and it requires a functional cellular environment to proceed correctly. When insulin resistance is present, that conversion is impaired.
The consequence is a particular kind of invisible problem: your TSH looks fine because your thyroid is producing T4 at normal levels. But your cells are receiving less T3 than they need. Cellular hypothyroidism exists even though the standard screening marker appears normal. In PCOS/PMOS, where chronically elevated insulin is already the baseline, this conversion impairment isn't a rare occurrence — it's the expected downstream effect.
You can read more about how insulin resistance drives the wider weight and metabolic picture in the weight loss resistance post.
Oestrogen dominance and thyroid binding globulin (TBG)
Elevated oestrogen — which is common in PCOS/PMOS, particularly when progesterone is relatively low — raises thyroid binding globulin (TBG). TBG is a protein that binds thyroid hormone in the bloodstream and renders it inactive while bound. When TBG is elevated, a larger proportion of circulating thyroid hormone is bound and therefore unavailable to cells.
The result, again, is that TSH can appear normal while functional thyroid activity is reduced. The hormone is present in the blood — it's just not free to act. Standard screening measures total thyroid hormone, not the free fraction that cells can actually use.
Autoimmune overlap
Hashimoto's thyroiditis is an autoimmune condition in which the immune system progressively destroys thyroid tissue. PCOS/PMOS has a significant autoimmune and inflammatory component — it shares HLA (human leucocyte antigen) genetic risk variants with several autoimmune conditions, including Hashimoto's. Chronic low-grade inflammation drives both.
This shared genetic architecture means that if you have PCOS/PMOS, your immune system is already operating in an environment that predisposes autoimmune activity. Hashimoto's isn't a coincidental co-occurrence — it's an overlapping condition that emerges from the same inflammatory substrate.
Cortisol and TSH suppression
HPA axis dysregulation — chronically elevated cortisol — is common in PCOS/PMOS. Elevated cortisol directly suppresses TSH production. When TSH is suppressed by cortisol, the thyroid receives less stimulation and slows its output. The mechanism is straightforward: stress makes both conditions worse through the same pathway. High cortisol → suppressed TSH → reduced thyroid activity → worsened PCOS/PMOS metabolic symptoms → elevated cortisol.
What Your Atlas Check-In Data Is Telling You
Thyroid involvement compounding PCOS/PMOS produces a specific pattern in daily check-in data — one that's distinct from standard PCOS/PMOS symptom patterns when you know what to look for.
Morning energy consistently below 4, regardless of sleep quality
Cellular hypothyroidism — reduced T3 reaching cells — drains mitochondrial ATP production. ATP is the cellular energy currency. When mitochondria are working with insufficient T3, energy production is impaired at the cellular level, not the behavioural level. If your morning energy score is consistently low even after nights where your sleep quality score is high, you're looking at a cellular energy problem rather than a sleep problem. Better sleep doesn't fix a T3 deficit. That's the distinction worth tracking.
Weight stalling and puffiness that doesn't respond to food changes
Hypothyroid slows lymphatic drainage and metabolic rate independently of caloric intake. The quality of hypothyroid weight gain is distinct from insulin-resistance weight gain — it has a particular puffiness, particularly around the face and extremities, and it responds very poorly to caloric manipulation. If you've adjusted food composition — lower GI, higher protein, the changes that typically move insulin-resistance weight — and the scale hasn't responded, thyroid metabolic depression is worth considering.
Hair loss tracking alongside energy dips
Both PCOS androgens and thyroid dysfunction cause telogen effluvium — a form of hair shedding where the follicle enters the resting phase prematurely and sheds several months later. The patterns are diagnostically different, however. Androgen-driven hair loss in PCOS/PMOS follows a specific distribution: temples, crown, the hairline. Thyroid-driven hair loss is diffuse — evenly spread across the entire scalp, including the sides and back.
The hair loss tracking post covers the distinction between androgen-patterned and diffuse loss in more detail. What matters for this question is whether the hair loss is concentrated in androgen-sensitive areas (more likely PCOS-driven) or evenly distributed (more likely thyroid-driven). Logging hair loss as a symptom in Atlas alongside energy scores allows you to see whether the two move together — which would point toward a shared driver.
Cold sensitivity logged on low-energy days
T3 is one of the primary regulators of basal metabolic rate and heat production. When T3 is low, the body produces less heat as a consequence — not because you're ill, but because thermogenesis is running at reduced capacity. If you're consistently logging cold sensitivity on the same days your energy score is low, that co-occurrence is a thyroid signal rather than a PCOS signal. PCOS doesn't produce cold sensitivity independently. Thyroid does.
Brain fog that doesn't correlate with food or cycle phase
PCOS brain fog has predictable cycle-phase triggers: it's worst in the early follicular phase when oestradiol is lowest, and in the luteal phase when progesterone alters neurotransmitter balance. It responds to food composition — a high-carb day produces identifiable cognitive lag the following day. Thyroid brain fog is different in character: it's flatter, more constant, and doesn't move reliably with cycle day or food choices. If your brain fog shows a cyclical pattern in your data, it's more likely PCOS-driven. If it's a flat baseline that never significantly improves, thyroid is worth ruling out.
Three Patterns Worth Tracking Over 14+ Days
Energy vs. sleep quality overlay
Log both your morning energy score and your sleep quality score every day for a minimum of two weeks. Then look at the correlation. Most people find that energy and sleep quality move together — a good night's sleep produces higher morning energy. If yours don't — if your energy score is consistently low even on days following high sleep quality scores — that decoupling is a meaningful thyroid signal rather than a cortisol or cycle signal. The pattern engine's sleep vs. energy correlation will surface this automatically.
Hair loss event vs. energy dip timing
Log hair shedding as a symptom in your check-ins — not just when it's severe, but consistently. Telogen effluvium operates on a 6–8 week delay: the follicle enters the resting phase in response to a stressor and sheds approximately six to eight weeks later. If your hair loss events cluster 6–8 weeks after sustained low-energy periods in your data, that delay pattern is a strong marker for hypothyroid hair loss rather than androgen-pattern loss, which follows the cycle more directly.
Weight trend vs. food composition
Track both your food composition — low-carb or higher-carb weeks — and your weight trend alongside your energy score. If your weight trends upward even during weeks where food composition is controlled (low GI, higher protein, energy intake consistent), and energy remains low in those same weeks, the insulin-T4 conversion pathway is likely impaired. Calorie counting misses this entirely because the mechanism isn't caloric. Food type tracking alongside weight and energy is what makes it visible.
> "The most important insight your data can give you isn't a single number — it's the pattern that doesn't fit. When your symptoms don't respond to the usual levers, that's when the thyroid question is worth asking your GP."
What to Do With the Insight
Experiment 1: Selenium and zinc for 30 days
Selenium and zinc are both required cofactors for T4 to T3 conversion. They're also among the most commonly depleted micronutrients in women with PCOS/PMOS, partly due to dietary patterns and partly due to the metabolic demands of chronic insulin resistance and inflammation. Supplementing both isn't a cure, but it's a measurable experiment: log your energy score and brain fog score for 30 days before starting, then 30 days after. A meaningful improvement in those scores during the second window — without other changes — provides evidence that micronutrient depletion was contributing to your T4 conversion problem.
Experiment 2: Track across both sides of the insulin-thyroid cycle
Eat a consistent low-GI diet for two weeks and log energy, weight trend, and brain fog throughout. The hypothesis you're testing: if insulin resistance is primarily driving your T4 conversion impairment, reducing insulin load should produce measurable improvements in those three markers within the two-week window. If improvements are rapid and pronounced, insulin-driven conversion impairment is the more likely mechanism. If improvements are minimal despite consistent low-GI eating, thyroid autoimmune load is the more likely driver — and warrants a full thyroid antibody panel rather than just a metabolic intervention.
Experiment 3: The GP conversation
When you go to your GP, don't only ask for TSH. TSH alone is insufficient to diagnose the specific mechanisms described above. Request a full panel: free T3 (fT3), free T4 (fT4), anti-TPO antibodies (the primary marker for Hashimoto's), and HOMA-IR (insulin resistance). These four tests together give a picture of both the conversion pathway and the autoimmune component.
Bring 30 days of Atlas data showing the flat-energy pattern — energy consistently low regardless of sleep quality — and the hair loss timing if relevant. The GP appointment guide covers how to present this data effectively. Most GPs will act on a full panel request backed by a consistent symptom pattern far faster than on symptoms described from memory alone.
You don't need a diagnosis to start seeing the pattern. You need 30 days of consistent check-ins and a willingness to notice what doesn't fit.
Start Tracking the Pattern That Doesn't Fit
Start Atlas Essential and begin building the data your GP needs to take the thyroid question seriously.